Sumitomo Dainippon Pharma Co's market cap is currently ―. The company's EPS TTM is $-4.749; its P/E ratio is ―; Sumitomo Dainippon Pharma Co is scheduled to report earnings on January 31, 2025, and the estimated EPS forecast is $0.26. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 140.98B	$ 159.41B	$ 159.88B	$ 127.96B	$ 138.34B
Gross Profit	$ 94.05B	$ 112.63B	$ 113.82B	$ 88.67B	$ 97.36B
EBIT	$ 11.14B	$ -24.71B	$ 47.49B	$ 18.14B	$ 17.09B
EBITDA	$ 20.86B	$ -13.87B	$ 59.01B	$ 28.30B	$ 27.18B
Net Income Common Stockholders	$ -11.22B	$ -38.39B	$ 31.11B	$ 10.05B	$ 9.91B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 288.26B	$ 276.02B	$ 265.59B	$ 238.58B	$ 208.08B
Total Assets	$ 1.37T	$ 1.41T	$ 1.42T	$ 1.31T	$ 1.30T
Total Debt	$ 249.71B	$ 249.71B	$ 268.91B	$ 269.05B	$ 269.75B
Net Debt	$ -38.55B	$ -26.30B	$ 3.32B	$ 30.47B	$ 61.67B
Total Liabilities	-	-	-	-	-
Stockholders Equity	$ 635.15B	$ 646.14B	$ 673.01B	$ 607.89B	$ 600.79B
Cash Flow	-
Free Cash Flow	$ 23.13B	$ 14.73B	$ 9.23B	$ 19.38B	$ 34.18B
Operating Cash Flow	$ 27.05B	$ 16.29B	$ 13.19B	$ 22.18B	$ 37.27B
Investing Cash Flow	$ 14.62B	$ -15.38B	$ 22.45B	$ -25.54B	$ 3.63B
Financing Cash Flow	$ -6.37B	$ -20.01B	$ -6.64B	$ -1.03B	$ -7.15B

Currency in USD

Sumitomo Dainippon Pharma Co Earnings and Revenue History

Income Statement >

Sumitomo Dainippon Pharma Co Debt to Assets

Balance Sheet >

Sumitomo Dainippon Pharma Co Cash Flow

Cash Flow >

Sumitomo Dainippon Pharma Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing